Flat-rate pricing · Discounts available · All-inclusive pricing No commitment required Online questionnaire, no video call · Free consultation Free expedited shipping · Supplies included · Discreet packaging Semaglutide · Zepbound, Mounjaro, Ozempic, Wegovy Priced higher than most providers Auto-renewing plans · $100 cancellation fee Pharmacy data not disclosed No verified LegitScript certification · Mixed customer reviews Not available in all statesProvider Plans Mounjaro Pen Tirzepatide Monthly Brand
Dose Your Supply Your Price Your Supply Avg/mo Your Value 2.5mg/wk 10mg/mo $1399.00 $1499.00 10mg 1399 $139.90/mg 5.0mg/wk 20mg/mo $1399.00 $1499.00 20mg 1399 $69.95/mg 7.5mg/wk 30mg/mo $1399.00 $1499.00 30mg 1399 $46.63/mg 10.0mg/wk 40mg/mo $1399.00 $1499.00 40mg 1399 $34.98/mg 12.5mg/wk 50mg/mo $1399.00 $1499.00 50mg 1399 $27.98/mg 15.0mg/wk 60mg/mo $1399.00 $1499.00 60mg 1399 $23.32/mg Sale price included
Zepbound Pen Tirzepatide Monthly Brand
Dose Your Supply Your Price Your Supply Avg/mo Your Value 2.5mg/wk 10mg/mo $1599.00 $1699.00 10mg 1599 $159.90/mg 5.0mg/wk 20mg/mo $1599.00 $1699.00 20mg 1599 $79.95/mg 7.5mg/wk 30mg/mo $1599.00 $1699.00 30mg 1599 $53.30/mg 10.0mg/wk 40mg/mo $1599.00 $1699.00 40mg 1599 $39.98/mg 12.5mg/wk 50mg/mo $1599.00 $1699.00 50mg 1599 $31.98/mg 15.0mg/wk 60mg/mo $1599.00 $1699.00 60mg 1599 $26.65/mg Sale price included
Provider Details In-House Rx Dose Adjustments By Provider
Prescription Included Yes
Telehealth Included Yes
Online-Only Option Yes
Skip Labs Not Disclosed
Credit Sale: Up To $100 Off Starter Sale: $50 Off
Insurance Accepted No
HSA/FSA Accepted No
Financing Available Not Disclosed
Sale Yes
Mixed Customer Reviews 10,000+ Patients
LegitScript Certified Not Disclosed
HIPAA Compliant Yes
Supplies Included Cold-Packed
Free Shipping Yes
Expedited Shipping Yes
Discreet Packaging Yes
Format: Oral Sublingual Brands: Ozempic Pen · Wegovy Pen · +2
Offers Tirzepatide Yes
Offers Semaglutide Yes
Offers Brand Yes
Other Treatments Yes
Phone (305) 563-9761
Address 3250 NE 1st Ave, Suite 305, Miami, FL 33137
Provider Notes Compliance The FDA resolved the semaglutide shortage on April 22, 2025. Compounding is permitted only for individually identified patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product.